Last synced on 20 December 2024 at 11:05 pm

Variola Virus Nucleic Acid-Based Detection Assay

Page Type
Product Code
Definition
The Variola virus nucleic acid-based detection assay is intended for individuals presenting with pustular or vesicular rash illness or other signs and symptoms of Variola virus infection. The test results must be used in conjunction with other diagnostic assays and clinical observations, as an aid to the diagnosis of infection, in accordance with the criteria defined by the appropriate public health authorities with the Federal government.
Physical State
The Variola virus nucleic acid-based detection assays are in vitro diagnostic devices that consist of reagents and associated instrumentation for the detection and identification of Variola virus nucleic acids in human clinical specimens.
Technical Method
Qualitative in vitro diagnostic assay that detects and identifies Variola virus nucleic acids in human clinical specimens.
Target Area
In vitro diagnostic device
Regulation Medical Specialty
Microbiology
Review Panel
Microbiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.3316
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code PRA is linked to regulation 21CFR866.3316, which does not seem to exist yet. It may be pending at the moment.

Variola Virus Nucleic Acid-Based Detection Assay

Page Type
Product Code
Definition
The Variola virus nucleic acid-based detection assay is intended for individuals presenting with pustular or vesicular rash illness or other signs and symptoms of Variola virus infection. The test results must be used in conjunction with other diagnostic assays and clinical observations, as an aid to the diagnosis of infection, in accordance with the criteria defined by the appropriate public health authorities with the Federal government.
Physical State
The Variola virus nucleic acid-based detection assays are in vitro diagnostic devices that consist of reagents and associated instrumentation for the detection and identification of Variola virus nucleic acids in human clinical specimens.
Technical Method
Qualitative in vitro diagnostic assay that detects and identifies Variola virus nucleic acids in human clinical specimens.
Target Area
In vitro diagnostic device
Regulation Medical Specialty
Microbiology
Review Panel
Microbiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.3316
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code PRA is linked to regulation 21CFR866.3316, which does not seem to exist yet. It may be pending at the moment.